JSM 2015 Online Program

Online Program Home
My Program

Abstract Details

Activity Number: 372
Type: Contributed
Date/Time: Tuesday, August 11, 2015 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract #315911
Title: Dose-Finding for Drug Combination in Early Cancer Phase I Trials Using Conditional Continual Reassessment Method
Author(s): Quanlin Li* and Mourad Tighiouart
Companies: and Cedars Sinai Medical Center
Keywords: Cancer phase I trials ; Maximum tolerated dose ; Continual reassessment method ; Drug combination ; Dose limiting toxicity ; Continuous dose

We present a Bayesian adaptive design for dose finding of a combination of two drugs in cancer phase I clinical trials. The goal is to estimate the maximum tolerated dose (MTD) as a curve for continuous dose levels of the two agents. Parametric models are used to describe the relationship between the doses and the probability of dose limiting toxicity (DLT). Trial design proceeds using the continual reassessment method, where at each stage of the trial, we seek the dose of one agent with estimated probability of DLT closest to a target probability of DLT given the current dose of the other agent. At the end of the trial, we estimate the MTD curve as a function of Bayes estimates of the model parameters. We evaluate design operating characteristics in terms of safety of the trial and percent of dose recommendation at dose combination neighborhoods around the true MTD. The method is further adapted to the case of a pre-specified discrete set of dose combinations and we show how more than one dose combination can be recommended as the MTD. We also examine the performance of the approach under model misspecifications for the true dose-toxicity relationship.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2015 program

For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home